Vanguard Asset Management
KURA icon

Vanguard Asset Management’s Kura Oncology KURA Stock Holding History

Vanguard Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$815K Buy
74,322
+23,115
+45% +$218K ﹤0.01% 1987
2026
Q1 		$416K Buy
+51,207
New +$440K ﹤0.01% 2179

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Asset Management's KURA Position: Q2 2026 in Review

Vanguard Asset Management increased its Kura Oncology (KURA) stake by 45% in Q2 2026, buying an estimated $218K and bringing the position to 74,322 shares worth $815K. The position accounts for ﹤0.01% of the portfolio, ranked #1987.

Vanguard Asset Management first reported a position in KURA in Q1 2026 and has held it in 2 quarters since. 205 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Vanguard Asset Management held 74,322 shares of Kura Oncology worth $815K as of Q2 2026.
  • Vanguard Asset Management bought 23,115 Kura Oncology shares in Q2 2026, an estimated $218K.
  • Kura Oncology made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1987 holding.
  • Vanguard Asset Management first reported a position in Kura Oncology in Q1 2026 and has held it in 2 quarters since.
  • 205 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.